Cooper Companies Inc
BMV:COO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cooper Companies Inc
EPS (Diluted)
Cooper Companies Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cooper Companies Inc
BMV:COO
|
EPS (Diluted)
$2
|
CAGR 3-Years
2%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
7%
|
|
|
Haemonetics Corp
NYSE:HAE
|
EPS (Diluted)
$3
|
CAGR 3-Years
26%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-36%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
EPS (Diluted)
$5
|
CAGR 3-Years
7%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
12%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
EPS (Diluted)
$3
|
CAGR 3-Years
104%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
EPS (Diluted)
$2
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Cooper Companies Inc
Glance View
In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.
See Also
What is Cooper Companies Inc's EPS (Diluted)?
EPS (Diluted)
2
USD
Based on the financial report for Jan 31, 2026, Cooper Companies Inc's EPS (Diluted) amounts to 2 USD.
What is Cooper Companies Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
7%
Over the last year, the EPS (Diluted) growth was -1%. The average annual EPS (Diluted) growth rates for Cooper Companies Inc have been 2% over the past three years , -29% over the past five years , and 7% over the past ten years .